NL180479C - Werkwijze voor de bereiding of vervaardiging van geneesmiddelen met ontstekingsremmende en corticoide activiteit, gevormde geneesmiddelen alsmede werkwijze voor de bereiding van 1,4-pregnadieenverbindingen, geschikt voor het gebruik als werkzame stof in deze geneesmiddelen. - Google Patents
Werkwijze voor de bereiding of vervaardiging van geneesmiddelen met ontstekingsremmende en corticoide activiteit, gevormde geneesmiddelen alsmede werkwijze voor de bereiding van 1,4-pregnadieenverbindingen, geschikt voor het gebruik als werkzame stof in deze geneesmiddelen.Info
- Publication number
- NL180479C NL180479C NLAANVRAGE7714056,A NL7714056A NL180479C NL 180479 C NL180479 C NL 180479C NL 7714056 A NL7714056 A NL 7714056A NL 180479 C NL180479 C NL 180479C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- pregnadadia
- inflammatory
- manufacture
- properties
- Prior art date
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
- E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
- E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
- E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Architecture (AREA)
- Engineering & Computer Science (AREA)
- Civil Engineering (AREA)
- Mechanical Engineering (AREA)
- Structural Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75325676A | 1976-12-22 | 1976-12-22 | |
| US05/753,257 US4076708A (en) | 1976-12-22 | 1976-12-22 | Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7714056A NL7714056A (nl) | 1978-06-26 |
| NL180479B NL180479B (nl) | 1986-10-01 |
| NL180479C true NL180479C (nl) | 1987-03-02 |
Family
ID=27115720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7714056,A NL180479C (nl) | 1976-12-22 | 1977-12-19 | Werkwijze voor de bereiding of vervaardiging van geneesmiddelen met ontstekingsremmende en corticoide activiteit, gevormde geneesmiddelen alsmede werkwijze voor de bereiding van 1,4-pregnadieenverbindingen, geschikt voor het gebruik als werkzame stof in deze geneesmiddelen. |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS604198B2 (da) |
| AR (1) | AR226806A1 (da) |
| AT (2) | AT373269B (da) |
| BE (1) | BE862089A (da) |
| DE (1) | DE2756550C2 (da) |
| DK (1) | DK153494C (da) |
| FI (1) | FI63947C (da) |
| FR (1) | FR2384793A1 (da) |
| GB (1) | GB1575983A (da) |
| HK (1) | HK584A (da) |
| HU (1) | HU179784B (da) |
| IE (1) | IE45950B1 (da) |
| IL (1) | IL53636A (da) |
| MY (1) | MY8500082A (da) |
| NL (1) | NL180479C (da) |
| NO (1) | NO151826C (da) |
| NZ (1) | NZ186031A (da) |
| PT (1) | PT67432B (da) |
| SE (1) | SE429865B (da) |
| SG (1) | SG58683G (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109680036A (zh) | 2017-10-02 | 2019-04-26 | 爱科来株式会社 | 糖化蛋白质的测定 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3429926A (en) * | 1964-05-25 | 1969-02-25 | Squibb & Sons Inc | 7-halo and 6-halo,6-dehydro a-norprogesterones |
-
1977
- 1977-12-13 GB GB51805/77A patent/GB1575983A/en not_active Expired
- 1977-12-19 DE DE2756550A patent/DE2756550C2/de not_active Expired
- 1977-12-19 FR FR7738297A patent/FR2384793A1/fr active Granted
- 1977-12-19 NO NO774359A patent/NO151826C/no unknown
- 1977-12-19 IE IE2576/77A patent/IE45950B1/en not_active IP Right Cessation
- 1977-12-19 JP JP52152835A patent/JPS604198B2/ja not_active Expired
- 1977-12-19 FI FI773825A patent/FI63947C/sv not_active IP Right Cessation
- 1977-12-19 AT AT0909477A patent/AT373269B/de not_active IP Right Cessation
- 1977-12-19 IL IL53636A patent/IL53636A/xx unknown
- 1977-12-19 PT PT67432A patent/PT67432B/pt unknown
- 1977-12-19 NZ NZ186031A patent/NZ186031A/en unknown
- 1977-12-19 NL NLAANVRAGE7714056,A patent/NL180479C/xx not_active IP Right Cessation
- 1977-12-19 AR AR270418A patent/AR226806A1/es active
- 1977-12-20 BE BE183654A patent/BE862089A/xx not_active IP Right Cessation
- 1977-12-20 DK DK569977A patent/DK153494C/da not_active IP Right Cessation
- 1977-12-20 SE SE7714538A patent/SE429865B/sv not_active IP Right Cessation
- 1977-12-21 HU HU77SCHE635A patent/HU179784B/hu unknown
-
1980
- 1980-11-25 AT AT0575980A patent/AT377566B/de not_active IP Right Cessation
-
1983
- 1983-09-09 SG SG586/83A patent/SG58683G/en unknown
-
1984
- 1984-01-05 HK HK5/84A patent/HK584A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY82/85A patent/MY8500082A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7514940A (nl) | Werkwijze voor het bereiden van azolyl-1 methanen en de zouten daarvan, alsmede de toe- passing daarvan als geneesmiddelen. | |
| NL7607338A (nl) | Werkwijze voor de bereiding van 1,4-dihydro- pyrinederivaten met vaatverwijdende en bloed- drukverlagende activiteit. | |
| NL7712106A (nl) | Werkwijze voor de bereiding van ml-236b carbon- zuurverbindingen en hun toepassing met hyperli- pemie-bestrijdende werking, alsmede aldus ver- kregen gevormd geneesmiddel. | |
| NL7601823A (nl) | Werkwijze voor het bereiden van 1.4-dihydropyri- dinecarbonzuuraralkylesters, alsmede de toepassing daarvan als geneesmiddelen. | |
| NL188681C (nl) | Geneesmiddel voor het verbeteren van de doorbloeding en wondgenezing. | |
| NL7701849A (nl) | Werkwijze voor de bereiding van geneesmiddelen onder toepassing van pyrethrinoiden. | |
| NL7701909A (nl) | Werkwijze voor de bereiding van een geneesmiddel tegen kanker, werkwijze voor de bereiding van de actieve component en het bereide geneesmiddel. | |
| NL7702829A (nl) | Werkwijze voor het continu bereiden van kiemvrije mayonaise en/of mayonaise-houdende produkten. | |
| NL167436C (nl) | Werkwijze voor de bereiding van 7beta-acylamino- -7alfa-alkoxycefalosporinen en 6beta-acylamino- -6alfa- alkoxypenicillinen, alsmede gevormd genees- middel. | |
| NL7612200A (nl) | Retinezuurderivaat alsmede farmaceutisch preparaat voor de behandeling van acne. | |
| NL7709508A (nl) | Werkwijzen voor het bereiden van aminoalkylideen- amino-1,4-dihydropyridinen, alsmede de toepas- sing van deze verbindingen als geneesmiddel. | |
| NL7511927A (nl) | Werkwijze voor het bereiden van farmacologisch werkzame pyridinederivaten en werkwijze voor de bereiding van een geneesmiddel op basis van deze derivaten. | |
| NL7702090A (nl) | Werkwijze voor de bereiding van gecondenseerde 5,6-gesubstitueerde 4-aminoalkoxy (2) 2,3-pyranon- verbindingen en hun additiezouten en tussenpro- dukten alsmede gevormd farmaceutisch preparaat. | |
| NL7501914A (nl) | Werkwijze voor het bereiden van cefalosporinen, alsmede de toepassing daarvan als farmaceutische preparaten. | |
| NL7700637A (nl) | Werkwijze voor het bereiden van gestogeenesters, alsmede geneesmiddelen, die deze esters bevatten. | |
| NL180585C (nl) | Werkwijze voor de bereiding van oxim-ethers, alsmede werkwijze voor de bereiding of vervaardiging van farmaceutische preparaten die deze bevatten. | |
| NL7704768A (nl) | Werkwijze voor de bereiding en de toepassing van pharmaceutische producten voor de dierge- neeskunde. | |
| NL7704320A (nl) | Werkwijze voor het bereiden van farmaceutische preparaten alsmede de door toepassing daarvan verkregen gevormde voortbrengselen. | |
| NL7603594A (nl) | Werkwijze voor het bereiden van carbonzuuramiden, alsmede de toepassing daarvan als farmaceutische preparaten. | |
| NL180479C (nl) | Werkwijze voor de bereiding of vervaardiging van geneesmiddelen met ontstekingsremmende en corticoide activiteit, gevormde geneesmiddelen alsmede werkwijze voor de bereiding van 1,4-pregnadieenverbindingen, geschikt voor het gebruik als werkzame stof in deze geneesmiddelen. | |
| NL7806381A (nl) | Pyridazinylhydrazonverbindingen en werkwijze voor de bereiding hiervan evenals de toepassing van deze ver- bindingen in farmaceutische produkten. | |
| NL173525B (nl) | Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met hoeststillende werking, alsmede werkwijze voor het bereiden van een daarin als werkzame stof te gebruiken 2-amino-4,5,7,8-tetrahydro-6h-oxazolo-5,4-dazepine. | |
| NL7704395A (nl) | Werkwijze voor de bereiding van n-glycosylderi- vaten van polyeenmacrolide en de toepassing hiervan als geneesmiddel. | |
| NL7706076A (nl) | Geneesmiddel met heterocyclische verbindingen en werkwijze voor het bereiden van heterocycli- sche verbindingen. | |
| NL7511943A (nl) | Werkwijze voor het bereiden van farmaceutische preparaten op basis van 1.2-difenylethanolen, alsmede hun toepassing als antiontstekingsmiddel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BATV | A request for search has been withdrawn | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 971219 |